平博pinnacle

  • 695a1e2987f75
    Cancel
    Date：2026-01
    /index.php?a=shows&catid=34&id=919

    Recently, MicroCyto announced the closing of a new round of equity financing worth nearly 300 million RMB. The investors include Beijing New Materials Industry Investment Fund, Beijing Medical and Health Industry Investment Fund, Zhongguancun Capital, and

  • 68be8db3cb6ab
    Cancel
    Date：2025-09
    /index.php?a=shows&catid=34&id=908

    iRegene, a biotech company committed to becoming a global leader in universal chemically induced cell therapies, recently announced the successful completion of its Series B+ financing round. The round was jointly led by Northern Light Venture Capital, Ch

  • 6823080abb87c
    Cancel
    Date：2025-04

    Exclusive Financial Advisor to IREGENE

  • 67e0cbac60773
    Cancel
    Date：2025-03
    /index.php?a=shows&catid=34&id=873

    Recently, Geneus Technologies, a leading domestic company in nanopore sequencing technology, announced the completion of a nearly RMB 100 million B++ round of financing. This round of funding was led by CDBT Group, with participation from Si Chuan Venture

  • 67b5a4b6895ca
    Cancel
    Date：2025-02

    Exclusive Financial Advisor to QL Biopharm

  • 6721d589391b1
    Cancel
    Date：2024-10
    /index.php?a=shows&catid=34&id=854

    Recently, Dingzhi Dental, a leading brand and expert in complex dental implants in China, announced the closing of its Series A financing, raising several hundred million RMB, with Eight Roads as the sole investor. CEC Capital served as the exclusive

  • 66d16f292654a
    Cancel
    Date：2024-08
    /index.php?a=shows&catid=34&id=842

    MicroCyto announced that it has raised over 300 million yuan in Series A financing. The round was led by Beijing Jingguorui Investment, with participation from Beijing Medical and Health Industry Investment Fund, Shenzhen Capital Group, and Hebei Producti

  • 6687ac98b5470
    Cancel
    Date：2024-07
    /index.php?a=shows&catid=34&id=839

    MoonBiotech announced that it has recently completed a RMB 300 million Series C+ financing, solely invested by SDIC JULI Investment Management Co., LTD. This financing round follows the Series C funding involving SDIC Venture Capital, marking another inst

  • 66580d7c774ac
    Cancel
    Date：2024-05
    /index.php?a=shows&catid=34&id=775

    Recently, Blue Sail Medical (002382.SZ) announced that its cardiovascular and cerebrovascular business unit, Blue Sail Biosensors, has raised a total of RMB 1 billion in funding. The Series A2 round introduced an additional RMB 100 million, following a RM


【网站地图】